Logo image of SBH

SALLY BEAUTY HOLDINGS INC (SBH) Stock Fundamental Analysis

NYSE:SBH - New York Stock Exchange, Inc. - US79546E1047 - Common Stock - Currency: USD

9.82  -0.18 (-1.8%)

After market: 9.82 0 (0%)

Fundamental Rating

5

Overall SBH gets a fundamental rating of 5 out of 10. We evaluated SBH against 121 industry peers in the Specialty Retail industry. While SBH belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. SBH is valued quite cheap, while showing a decent growth score. This is a good combination! These ratings would make SBH suitable for value investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year SBH was profitable.
SBH had a positive operating cash flow in the past year.
Each year in the past 5 years SBH has been profitable.
In the past 5 years SBH always reported a positive cash flow from operatings.
SBH Yearly Net Income VS EBIT VS OCF VS FCFSBH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

1.2 Ratios

With a decent Return On Assets value of 6.87%, SBH is doing good in the industry, outperforming 76.86% of the companies in the same industry.
Looking at the Return On Equity, with a value of 26.58%, SBH belongs to the top of the industry, outperforming 84.30% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 10.99%, SBH is in the better half of the industry, outperforming 76.86% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for SBH is in line with the industry average of 13.07%.
Industry RankSector Rank
ROA 6.87%
ROE 26.58%
ROIC 10.99%
ROA(3y)6.46%
ROA(5y)6.35%
ROE(3y)41.08%
ROE(5y)188.75%
ROIC(3y)11.72%
ROIC(5y)11.63%
SBH Yearly ROA, ROE, ROICSBH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400 -400 600

1.3 Margins

Looking at the Profit Margin, with a value of 5.03%, SBH is in the better half of the industry, outperforming 77.69% of the companies in the same industry.
SBH's Profit Margin has declined in the last couple of years.
The Operating Margin of SBH (8.75%) is better than 81.82% of its industry peers.
In the last couple of years the Operating Margin of SBH has declined.
Looking at the Gross Margin, with a value of 51.26%, SBH belongs to the top of the industry, outperforming 80.17% of the companies in the same industry.
SBH's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 8.75%
PM (TTM) 5.03%
GM 51.26%
OM growth 3Y-11.35%
OM growth 5Y-8.43%
PM growth 3Y-12.64%
PM growth 5Y-10.04%
GM growth 3Y0.3%
GM growth 5Y0.63%
SBH Yearly Profit, Operating, Gross MarginsSBH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

5

2. Health

2.1 Basic Checks

SBH has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
SBH has less shares outstanding than it did 1 year ago.
SBH has less shares outstanding than it did 5 years ago.
SBH has a better debt/assets ratio than last year.
SBH Yearly Shares OutstandingSBH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
SBH Yearly Total Debt VS Total AssetsSBH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

An Altman-Z score of 2.80 indicates that SBH is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.80, SBH is doing good in the industry, outperforming 64.46% of the companies in the same industry.
SBH has a debt to FCF ratio of 6.14. This is a slightly negative value and a sign of low solvency as SBH would need 6.14 years to pay back of all of its debts.
The Debt to FCF ratio of SBH (6.14) is better than 61.98% of its industry peers.
SBH has a Debt/Equity ratio of 1.29. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.29, SBH is doing worse than 61.98% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.29
Debt/FCF 6.14
Altman-Z 2.8
ROIC/WACC1.13
WACC9.75%
SBH Yearly LT Debt VS Equity VS FCFSBH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 2.32 indicates that SBH has no problem at all paying its short term obligations.
The Current ratio of SBH (2.32) is better than 85.95% of its industry peers.
SBH has a Quick Ratio of 2.32. This is a bad value and indicates that SBH is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.44, SBH perfoms like the industry average, outperforming 42.98% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.32
Quick Ratio 0.44
SBH Yearly Current Assets VS Current LiabilitesSBH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 8.43% over the past year.
Measured over the past years, SBH shows a decrease in Earnings Per Share. The EPS has been decreasing by -5.65% on average per year.
SBH shows a small growth in Revenue. In the last year, the Revenue has grown by 0.17%.
SBH shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.84% yearly.
EPS 1Y (TTM)8.43%
EPS 3Y-10.79%
EPS 5Y-5.65%
EPS Q2Q%20%
Revenue 1Y (TTM)0.17%
Revenue growth 3Y-1.38%
Revenue growth 5Y-0.84%
Sales Q2Q%-2.78%

3.2 Future

Based on estimates for the next years, SBH will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.05% on average per year.
SBH is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.85% yearly.
EPS Next Y3.87%
EPS Next 2Y7.12%
EPS Next 3Y9.05%
EPS Next 5YN/A
Revenue Next Year-1.01%
Revenue Next 2Y0.19%
Revenue Next 3Y0.85%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SBH Yearly Revenue VS EstimatesSBH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B
SBH Yearly EPS VS EstimatesSBH Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

8

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 5.46, the valuation of SBH can be described as very cheap.
SBH's Price/Earnings ratio is rather cheap when compared to the industry. SBH is cheaper than 96.69% of the companies in the same industry.
SBH is valuated cheaply when we compare the Price/Earnings ratio to 27.30, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 5.06, the valuation of SBH can be described as very cheap.
SBH's Price/Forward Earnings ratio is rather cheap when compared to the industry. SBH is cheaper than 93.39% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.76. SBH is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 5.46
Fwd PE 5.06
SBH Price Earnings VS Forward Price EarningsSBH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

89.26% of the companies in the same industry are more expensive than SBH, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of SBH indicates a rather cheap valuation: SBH is cheaper than 92.56% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 6.71
EV/EBITDA 4.25
SBH Per share dataSBH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of SBH may justify a higher PE ratio.
PEG (NY)1.41
PEG (5Y)N/A
EPS Next 2Y7.12%
EPS Next 3Y9.05%

0

5. Dividend

5.1 Amount

No dividends for SBH!.
Industry RankSector Rank
Dividend Yield N/A

SALLY BEAUTY HOLDINGS INC

NYSE:SBH (7/11/2025, 8:04:00 PM)

After market: 9.82 0 (0%)

9.82

-0.18 (-1.8%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)05-12 2025-05-12/bmo
Earnings (Next)07-31 2025-07-31/amc
Inst Owners121.38%
Inst Owner Change0%
Ins Owners0.86%
Ins Owner Change2.88%
Market Cap990.74M
Analysts71.11
Price Target12.24 (24.64%)
Short Float %15.13%
Short Ratio8.24
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.43%
Min EPS beat(2)-1.32%
Max EPS beat(2)6.17%
EPS beat(4)3
Avg EPS beat(4)4.98%
Min EPS beat(4)-1.32%
Max EPS beat(4)10.65%
EPS beat(8)4
Avg EPS beat(8)0.46%
EPS beat(12)7
Avg EPS beat(12)1.17%
EPS beat(16)10
Avg EPS beat(16)2.51%
Revenue beat(2)0
Avg Revenue beat(2)-2.31%
Min Revenue beat(2)-3%
Max Revenue beat(2)-1.61%
Revenue beat(4)1
Avg Revenue beat(4)-1.38%
Min Revenue beat(4)-3%
Max Revenue beat(4)0.14%
Revenue beat(8)1
Avg Revenue beat(8)-1.51%
Revenue beat(12)5
Avg Revenue beat(12)-0.5%
Revenue beat(16)7
Avg Revenue beat(16)-0.63%
PT rev (1m)-9.09%
PT rev (3m)-5.88%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-8.27%
EPS NY rev (1m)0.46%
EPS NY rev (3m)-3.73%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.33%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.99%
Valuation
Industry RankSector Rank
PE 5.46
Fwd PE 5.06
P/S 0.27
P/FCF 6.71
P/OCF 4.08
P/B 1.42
P/tB 9.02
EV/EBITDA 4.25
EPS(TTM)1.8
EY18.33%
EPS(NY)1.94
Fwd EY19.75%
FCF(TTM)1.46
FCFY14.9%
OCF(TTM)2.41
OCFY24.54%
SpS36.66
BVpS6.94
TBVpS1.09
PEG (NY)1.41
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.87%
ROE 26.58%
ROCE 14.9%
ROIC 10.99%
ROICexc 11.48%
ROICexgc 16.03%
OM 8.75%
PM (TTM) 5.03%
GM 51.26%
FCFM 3.99%
ROA(3y)6.46%
ROA(5y)6.35%
ROE(3y)41.08%
ROE(5y)188.75%
ROIC(3y)11.72%
ROIC(5y)11.63%
ROICexc(3y)12.3%
ROICexc(5y)13.11%
ROICexgc(3y)17.54%
ROICexgc(5y)19.12%
ROCE(3y)15.88%
ROCE(5y)15.76%
ROICexcg growth 3Y-19.08%
ROICexcg growth 5Y-16.57%
ROICexc growth 3Y-17.14%
ROICexc growth 5Y-14.25%
OM growth 3Y-11.35%
OM growth 5Y-8.43%
PM growth 3Y-12.64%
PM growth 5Y-10.04%
GM growth 3Y0.3%
GM growth 5Y0.63%
F-Score9
Asset Turnover1.37
Health
Industry RankSector Rank
Debt/Equity 1.29
Debt/FCF 6.14
Debt/EBITDA 2.1
Cap/Depr 90.38%
Cap/Sales 2.58%
Interest Coverage 4.51
Cash Conversion 56.62%
Profit Quality 79.36%
Current Ratio 2.32
Quick Ratio 0.44
Altman-Z 2.8
F-Score9
WACC9.75%
ROIC/WACC1.13
Cap/Depr(3y)93.39%
Cap/Depr(5y)91.26%
Cap/Sales(3y)2.59%
Cap/Sales(5y)2.56%
Profit Quality(3y)70.61%
Profit Quality(5y)123.87%
High Growth Momentum
Growth
EPS 1Y (TTM)8.43%
EPS 3Y-10.79%
EPS 5Y-5.65%
EPS Q2Q%20%
EPS Next Y3.87%
EPS Next 2Y7.12%
EPS Next 3Y9.05%
EPS Next 5YN/A
Revenue 1Y (TTM)0.17%
Revenue growth 3Y-1.38%
Revenue growth 5Y-0.84%
Sales Q2Q%-2.78%
Revenue Next Year-1.01%
Revenue Next 2Y0.19%
Revenue Next 3Y0.85%
Revenue Next 5YN/A
EBIT growth 1Y9.92%
EBIT growth 3Y-12.57%
EBIT growth 5Y-9.19%
EBIT Next Year36.81%
EBIT Next 3Y14.73%
EBIT Next 5YN/A
FCF growth 1Y4.32%
FCF growth 3Y-22.14%
FCF growth 5Y-7.32%
OCF growth 1Y1.75%
OCF growth 3Y-13.58%
OCF growth 5Y-5.11%